Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 4576 AL 4590

Disease-Modifying Therapies for Alzheimer's Disease: More Questions than Answers

Golde TE.

Neurotherapeutics. 2022 Jan;19(1):209-227. doi: 10.1007/s13311-022-01201-2. Epub 2022 Feb 28.

Acupuncture-related treatments improve cognitive and physical functions in Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials

Lin CJ, Yeh ML, Wu SF, Chung YC, Lee JC.

Clin Rehabil. 2022 May;36(5):609-635. doi: 10.1177/02692155221079117. Epub 2022 Mar 1.

Stem cell therapy for Alzheimer's disease: An overview of experimental models and reality

Qin C, Wang K, Zhang L, Bai L.

Animal Model Exp Med. 2022 Feb;5(1):15-26. doi: 10.1002/ame2.12207. Epub 2022 Jan 29.

Hippocampal neurogenesis and pro-neurogenic therapies for Alzheimer's disease

Zheng J.

Animal Model Exp Med. 2022 Feb;5(1):3-14. doi: 10.1002/ame2.12212. Epub 2022 Feb 6.

Mechanisms of Acupuncture in Improving Alzheimer's Disease Caused by Mitochondrial Damage

Jiang YH, He JK, Li R, Chen ZH, Jia BH.

Chin J Integr Med. 2022 Mar;28(3):272-280. doi: 10.1007/s11655-022-3511-6. Epub 2022 Mar 1.

"Aducanumab" making a comeback in Alzheimer's disease: An old wine in a new bottle

Behl T, Kaur I, Sehgal A, Singh S, Sharma N, Makeen HA, Albratty M, Alhazmi HA, Felemban SG, Alsubayiel AM, Bhatia S, Bungau S.

Biomed Pharmacother. 2022 Apr;148:112746. doi: 10.1016/j.biopha.2022.112746. Epub 2022 Feb 26.

APOE mediated neuroinflammation and neurodegeneration in Alzheimer's disease

Parhizkar S, Holtzman DM.

Semin Immunol. 2022 Jan;59:101594. doi: 10.1016/j.smim.2022.101594. Epub 2022 Feb 26.

Improving Brain Health for Populations Disproportionately Affected by Alzheimer's Disease and Related Dementias

Olivari BS, Jeffers EM, Tang KW, McGuire LC.

Clin Gerontol. 2023 Mar-Apr;46(2):128-132. doi: 10.1080/07317115.2022.2043977. Epub 2022 Mar 2.

Challenges and Approaches of Drugs Such as Memantine, Donepezil, Rivastigmine, and Aducanumab in the Treatment, Control and Management of Alzheimer's Disease

Saeedi M, Mehranfar F.

Recent Pat Biotechnol. 2022;16(2):102-121. doi: 10.2174/1872208316666220302115901.

Guidelines for bioinformatics of single-cell sequencing data analysis in Alzheimer's disease: review, recommendation, implementation and application

Wang M, Song WM, Ming C, Wang Q, Zhou X, Xu P, Krek A, Yoon Y, Ho L, Orr ME, Yuan GC, Zhang B.

Mol Neurodegener. 2022 Mar 2;17(1):17. doi: 10.1186/s13024-022-00517-z.

Medication reconciliation role and value in Alzheimer's disease treatment

Shen X, Zhang Q, Shao W, Shi J, Liu B.

Arq Neuropsiquiatr. 2022 Mar;80(3):233-239. doi: 10.1590/0004-282X-ANP-2021-0147.

Editorial: Honouring John Hardy - A true pioneer in research

Lourenco MV, Hausmann L.

J Neurochem. 2022 May;161(4):316-319. doi: 10.1111/jnc.15593. Epub 2022 Mar 3.

From synapses to circuits and back: Bridging levels of understanding in animal models of Alzheimer's disease

Chockanathan U, Padmanabhan K.

Eur J Neurosci. 2022 Nov;56(9):5564-5586. doi: 10.1111/ejn.15636. Epub 2022 Mar 14.

Periodontal microorganisms and Alzheimer disease - A causative relationship?

Jungbauer G, Stähli A, Zhu X, Auber Alberi L, Sculean A, Eick S.

Periodontol 2000. 2022 Jun;89(1):59-82. doi: 10.1111/prd.12429. Epub 2022 Mar 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias